Nanobiosensors and Artificial Intelligence Strategies for Glycan Profiling in Cancer Progression: A Critical Review.
리뷰
2/5 보강
OpenAlex 토픽 ·
Glycosylation and Glycoproteins Research
Biological Research and Disease Studies
Biosensors and Analytical Detection
Glycans are complex carbohydrates that are integral to cancer progression and tumor biology.
APA
Ramlah Khamis, Yuao Wu, et al. (2026). Nanobiosensors and Artificial Intelligence Strategies for Glycan Profiling in Cancer Progression: A Critical Review.. ACS sensors, 11(4), 2899-2922. https://doi.org/10.1021/acssensors.5c04911
MLA
Ramlah Khamis, et al.. "Nanobiosensors and Artificial Intelligence Strategies for Glycan Profiling in Cancer Progression: A Critical Review.." ACS sensors, vol. 11, no. 4, 2026, pp. 2899-2922.
PMID
41979907 ↗
Abstract 한글 요약
Glycans are complex carbohydrates that are integral to cancer progression and tumor biology. Conventional methods face challenges due to the structural diversity and low abundance of glycans, limiting the detection of cancer-associated glycan signatures. This bottleneck hampers the accurate monitoring of cancer progression and the development of effective diagnostic tools. Nanobiosensor-enabled glycan profiling overcomes conventional limitations by providing highly sensitive detection of low-abundance glycans and precise discrimination of similar forms through nanoscale electrochemical or optical signal amplification and selective biorecognition. This review evaluates emerging nanobiosensors, including optical modalities such as surface plasmon resonance, localized surface plasmon resonance, surface-enhanced Raman scattering, fluorescence, and colorimetric nanobiosensors. It also covers electrochemical systems, including impedimetric, voltammetric, and amperometric sensors that use nanomaterials to enhance the sensitivity, specificity, and reliability of glycan detection. After a critical evaluation of nanobiosensors, this review highlights their applications for glycan analysis in cancer progression and potential of miniaturized point-of-care platforms. In parallel, this review highlights emerging artificial intelligence (AI) and machine learning (ML) approaches that are being explored to analyse complex biosensor outputs. By enabling multivariate pattern recognition, dimensionality reduction, and nonlinear modeling of biosensor responses, these computational frameworks may facilitate the extraction of diagnostically relevant signatures from high-dimensional optical and electrochemical datasets. The review identifies challenges in standardization and clinical scalability of nanobiosensors and explores future directions, including AI integration to advance early cancer detection and personalized patient management.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.